Clinical Trial Update: A Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This is a Phase 2 neoadjuvant chemotherapy trial for Stage II-III esophageal squamous cell carcinoma. The current status is unknown per the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Stage II and III Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN